HLL Lifecare Limited Distributes Rs 69.5 Crore Dividend to Government for Financial Year 2024-25

HLL Lifecare Limited, a Mini-Ratna Central Public Sector Enterprise under the Union Health Ministry, has paid a dividend of Rs 69.53 crore to the Government of India for the financial year 2024-25. This amount ranks among the highest dividends ever paid by the company, according to a statement from the health ministry.

The dividend cheque was handed over to Union Health Minister J P Nadda by Dr Anitha Thampi, Chairperson of HLL Lifecare. Nadda praised HLL as a dependable entity in medical services, committed to providing accessible and affordable healthcare nationwide. He emphasized that HLL and its subsidiaries, along with Amrit pharmacies, have become pivotal in transforming the health sector.

Growth and Financial Performance

In the last decade, over 6.7 crore individuals have benefited from affordable medicines provided by Amrit Pharmacies, resulting in savings exceeding Rs 8,000 crore on out-of-pocket expenses. The financial year 2024-25 saw substantial growth across HLL's manufacturing and service sectors, as per the statement.

Revenue from operations surged to Rs 4,500 crore, indicating a 20% increase compared to the previous year. The company's net worth also rose significantly to Rs 1,100 crore as of March 31, 2025. On a consolidated basis, including subsidiaries like HITES, GAPL, and Lifespring Hospitals, the HLL Group achieved total revenue of Rs 4,900 crore, marking a 19% growth over the prior fiscal year.

Impact on Healthcare Sector

Nadda highlighted that HLL's efforts have significantly contributed to making healthcare more affordable for millions. The company's initiatives align with the national vision of ensuring quality healthcare for all citizens. The growth in revenue and net worth underscores HLL's expanding influence in both manufacturing and service domains.

The achievements of HLL Lifecare Limited reflect its commitment to enhancing healthcare accessibility and affordability across India. The company's financial success and strategic initiatives continue to play a crucial role in advancing the nation's health sector objectives.

With inputs from PTI